Reply to "The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations"

• Matsumura Tsuyoshi

  Department of Neurology, National Hospital Organization Toneyama National Hospital, Japan

• Iwata Yuko

  Department of Molecular Physiology, National Cerebral and Cardiovascular Center Research Institute, Japan

• Asakura Masanori

  Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, Japan

Journal

• Internal Medicine

  Internal Medicine 57 (14), 2101-2102, 2018-07-15

  The Japanese Society of Internal Medicine

Keywords

• muscular dystrophy
• cardiomyopathy
• cardioprotective therapy
• tranilast
• transient receptor potential cation channel
• subfamily V
• member 2 (TRPV2)

Details

• CRID: 1390845712973769984
• NII Article ID: 130007404905
• DOI: 10.2169/internalmedicine.0592-17
• ISSN: 13497235
• ISSN: 09182918
• PubMed: 29491287
• Web Site: https://www.jstage.jst.go.jp/article/internalmedicine/57/14/57_0592-17/_pdf
• Web Site: https://search.jamas.or.jp/link/ui/2019282349
• Text Lang: en
• Data Source:
  • JaLC
  • Crossref
  • PubMed
  • CiNii Articles
  • KAKEN